供应athens research & technologyBrand,K060-H1Item#,Athens Research & Technology；K060-H1；Myeloperoxidase Enzyme Immunoassay Kit

Athens Research & Technology；K060-H1；Myeloperoxidase Enzyme Immunoassay Kit

型号:K060-H1
联系人:程园
联系电话:18611717737
品牌:athens research & technology

Athens Research & Technology 公司位于美国乔治亚州雅典市，从1986年以来一直于纯化高纯度，高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白，血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来，世界各地的研究人员都在使用我们公司的产品。在炎症、状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。
我们提供质，可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务，Athens Research & Technology 公司能够根据您的项目要求提供的试剂。
产品te色
多种天然提取的人类蛋白质产品；多种兔抗人类蛋白质抗血清。

Human MPO EIA KIT FEATURES:

USE - Measure human MPO in a variety of matrices
SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media
SAMPLES / KIT - 40 in duplicate
SENSITIVITY - 0.068 ng/mL
STABILITY - liquid reagents stable at 4°C
QUICK RESULTS - 2.5 HOURS

Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency.

Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.

References:
Zhang et al. (2001) Association between myeloperoxidase levels and risk of coronary artery disease; JAMA, 286 2135
Brennan et al. (2003) Prognostic value of myeloperoxidase in patients with chest pain; New Engl. J. Med., 349 1595
Heslop et al. (2010) Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography; J. Am. Coll. Of Cardiol. 55 1102

Athens Research and Technology (ART) has partnered with Arbor Assays to offer the best MPO EIA kit available. The founders and top scientists from Arbor Assays have been researching and developing high quality assay kits since 1982, so ART utilized our 30 years of experience advancing and perfecting techniques in protein purification to isolate a superior quality antigen which the Arbor Assays team then developed into a top of the line EIA featuring a unique antibody pairing along with careful optimization and their trademark exceptional quality control. The Athens Research and Technology/Arbor Assays human MPO EIA kit has been validated for serum, platelet-poor heparin plasma, saliva, urine and tissue culture media with results in just 2.5 hours and a sensitivity of 0.68 ng/ml. The kit is available for purchase from either company (Arbor Assays cat.# K060-H1, Athens Research and Technology cat.# K060-H1).